ALLO Allogene Therapeutics, Inc. - Common Stock
$2,07
Kurs · Aug 18, 2026
Fundamentaldaten per Aug 12, 2026
52W-Spanne
$1–$4
30% of range
Analystenbewertung
BUY
18 analysts
Kursziel
$9
+336% upside
P/E (TTM)
-2.5
ROE
-59.9%
Nettogewinnmarge
—
ALLO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$2.06
Marktkapitalisierung
$506M
P/E (TTM)
-2.5
EPS (TTM)
$-0.87
Umsatz (TTM)
$0
Dividendenrendite
—
ROE
-59.9%
Verschuldungsgrad
—
52W-Spanne
$1 – $4
ALLO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$0
2022-12-31
→
2025-12-31
EPS
$-0.87
2022-12-31
→
2025-12-31
Freier Cashflow
$-150M
2023-12-31
→
2025-12-31
Margen
—
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
ALLO
Peer-Median
P/E (TTM)
-2.5
19.6
P/B (K/B)
1.7
2.6
Price / FCF (Kurs / FCF)
-3.4
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
ALLO
Peer-Median
ROA
-39.6%
-40.3%
ROE
-59.9%
-42.4%
ROIC
-71.5%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
ALLO
Peer-Median
Current Ratio (Liquiditätsgrad)
7.9
5.4
Quick Ratio
1.6
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
ALLO
Peer-Median
Revenue YoY (Umsatz YoY)
-76.8%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
-94.2%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
ALLO
Peer-Median
ALLO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
18 Analysten
- Starker Kauf 6 33,3%
- Kauf 10 55,6%
- Halten 2 11,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
9 Analysten · 2026-08-15
Median
$9.00
← Unter allen Zielen
$2.06
Tief
$4.00
Hoch
$14.00
Median-Ziel
$9.00
+335,8%
Mittelwert-Ziel
$9.00
+335,8%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
0.04%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.13 | $-0.17 | 0.04% |
| 31. März 2026 | $-0.18 | $-0.19 | 0.01% |
| 31. Dezember 2025 | $-0.17 | $-0.22 | 0.05% |
| 30. September 2025 | $-0.19 | $-0.23 | 0.04% |
| 30. Juni 2025 | $-0.23 | $-0.28 | 0.05% |
| 31. März 2025 | $-0.28 | $-0.30 | 0.02% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| ALLO | $314M | -1.6 | -76.8% | — | -59.9% | — |
| BBOT | $1.00B | -2.9 | — | — | -146.2% | — |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | — |
| SGMT | — | -3.7 | — | — | -42.3% | — |
| TECX | $391M | -5.2 | — | — | -27.7% | — |
| CBIO | $327M | -24.2 | -86.7% | -1419.6% | -90.0% | — |
| ASMB | $539M | -61.8 | 153.5% | -8.5% | -5.5% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $22.0K | $95.0K | $156.0K | $114M | $0 | $0 | |
| R&D Expense | $150M | $192M | $243M | $256M | $220M | $193M | $145M | |
| SG&A Expense | $57M | $65M | $72M | $79M | $74M | $65M | $57M | |
| Operating Expenses | $209M | $273M | $328M | $336M | $294M | $258M | $202M | |
| Operating Income | $-209M | $-273M | $-328M | $-336M | $-180M | $-258M | $-202M | |
| Interest Expense | · | · | · | · | · | $0 | $0 | |
| Other Non-op | $215.0K | $-4M | $-18M | $-9M | $-4M | $-67M | $17M | |
| Pretax Income | $-191M | $-257M | $-327M | · | $-257M | $-250M | $-185M | |
| Income Tax | $0 | $443.0K | $0 | $0 | $0 | $0 | $-331.0K | |
| Net Income | $-191M | $-258M | $-327M | $-340M | $-182M | $-316M | $-185M | |
| EPS (Basic) | $-0.87 | $-1.32 | $-2.09 | $-2.38 | $-1.34 | $-2.63 | $-1.83 | |
| EPS (Diluted) | $-0.87 | $-1.32 | $-2.09 | $-2.38 | $-1.34 | $-2.63 | $-1.83 | |
| Shares (Basic) | 220,622,669 | 194,811,756 | 156,931,778 | 143,147,165 | 135,820,386 | 120,370,177 | 101,061,149 | |
| Shares (Diluted) | 220,622,669 | 194,811,756 | 156,931,778 | 143,147,165 | 135,820,386 | 120,370,177 | 101,061,149 | |
| EBITDA | $-197M | $-260M | $-314M | · | $-245M | $-251M | $-197M |
Bilanz 21
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $52M | $75M | $83M | $62M | $173M | $183M | $175M | |
| Short-term Investments | · | · | · | · | $284M | $645M | $355M | |
| Prepaid Expense | $8M | $11M | $10M | $12M | $14M | $17M | $14M | |
| Current Assets | $258M | $303M | $459M | $529M | $471M | $845M | $545M | |
| PP&E (Net) | $73M | $86M | $99M | $113M | $123M | $119M | $56M | |
| PP&E (Gross) | $145M | $149M | $151M | $150M | $146M | $132M | $62M | |
| Accum. Depreciation | $73M | $63M | $51M | $37M | $23M | $13M | $5M | |
| Intangibles | · | · | · | · | · | $0 | $151.0K | |
| Other Non-current Assets | $4M | $2M | $7M | $10M | $6M | $5M | $5M | |
| Total Assets | $416M | $549M | $643M | $822M | $1.05B | $1.23B | $718M | |
| Accounts Payable | $4M | $5M | $6M | $14M | $10M | $10M | $9M | |
| Current Liabilities | $33M | $36M | $37M | $54M | $48M | $94M | $33M | |
| Capital Leases | $75M | $83M | $88M | $95M | $70M | $51M | $51M | |
| Other Non-current Liabilities | $16M | $8M | $5M | $6M | $8M | $3M | $4M | |
| Total Liabilities | $123M | $127M | $131M | $155M | $126M | $148M | $89M | |
| Common Stock | $229.0K | $212.0K | $169.0K | $144.0K | $142.0K | $140.0K | $124.0K | |
| Retained Earnings | $-2.01B | $-1.82B | $-1.56B | $-1.23B | $-895M | $-713M | $-396M | |
| AOCI | $269.0K | $-89.0K | $-955.0K | $-10M | $-3M | $268.0K | $1M | |
| Stockholders' Equity | $293M | $422M | $512M | $667M | $925M | $1.01B | $629M | |
| Liabilities + Equity | $416M | $549M | $643M | $822M | $1.05B | $1.23B | $718M | |
| Shares Outstanding | 229,413,523 | 212,210,597 | 168,642,238 | 144,438,304 | 142,623,065 | 140,474,305 | 124,267,358 |
Cashflow 15
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| D&A | $12M | $14M | $14M | $14M | $10M | $7M | $5M | |
| Stock-based Comp | $38M | $52M | $66M | $84M | $81M | $65M | $46M | |
| Deferred Tax | $0 | $443.0K | $0 | · | · | · | · | |
| Amort. of Intangibles | · | · | · | $0 | $0 | $151.0K | $603.0K | |
| Restructuring | $5M | · | · | · | · | · | · | |
| Other Non-cash | $-8M | $-9M | $9M | · | $-19M | $62M | $-3M | |
| Operating Cash Flow | $-149M | $-200M | $-238M | $-221M | $-185M | $-115M | $-137M | |
| CapEx | $386.0K | $694.0K | $2M | $5M | $21M | $66M | $51M | |
| Investing Cash Flow | $96M | $76M | $163M | $106M | $164M | $-505M | $164M | |
| Stock Issued | · | · | $91M | $0 | $0 | $596M | $0 | |
| Net Stock Activity | · | · | $91M | · | $0 | $622M | $54M | |
| Financing Cash Flow | $30M | $117M | $96M | $3M | $12M | $634M | $59M | |
| Net Change in Cash | $-24M | $-8M | $21M | $-111M | $-9M | $13M | $86M | |
| Free Cash Flow | $-150M | $-201M | $-239M | · | $-206M | $-181M | $-188M | |
| Levered FCF | · | · | · | · | · | $-181M | $-188M |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -1241813.6% | -344986.3% | · | -664.6% | · | · | |
| Net Margin | · | -1170863.6% | -344489.5% | · | -667.7% | · | · | |
| Pretax Margin | · | -1168850.0% | · | · | -667.7% | · | · | |
| EBITDA Margin | · | -1179818.2% | -330039.0% | · | -637.3% | · | · | |
| ROA | -39.6% | -43.2% | -48.3% | · | -22.7% | -25.7% | -24.8% | |
| ROE | -59.9% | -58.1% | -59.9% | · | -27.3% | -22.8% | -29.6% | |
| ROIC | -71.5% | -64.8% | · | · | -27.9% | -23.9% | -32.1% |
Liquidität & Solvenz 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.9 | 8.5 | 12.4 | · | 9.8 | 9.0 | 16.5 | |
| Quick Ratio | 1.6 | 2.1 | 2.2 | · | 9.5 | 8.8 | 16.0 |
Effizienz 1
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · |
Wachstumsraten 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | -76.8% | -39.1% | -99.9% | · | · | · | |
| Revenue CAGR 3Y | · | -94.2% | · | · | · | · | · |
Bewertung (TTM) 10
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $22.0K | $95.0K | $156.0K | $114M | $0 | $0 | |
| Net Income TTM | $-191M | $-258M | $-327M | $-340M | $-182M | $-316M | $-185M | |
| Market Cap | $314M | $452M | $541M | · | $2.13B | $3.55B | $3.23B | |
| P/E | -1.6 | -1.6 | -1.5 | -2.6 | -11.1 | -9.6 | -14.2 | |
| P/S | · | 20545.8 | 5698.3 | · | 18.7 | · | · | |
| P/B | 1.1 | 1.1 | 1.1 | · | 2.3 | 3.3 | 5.1 | |
| P / Tangible Book | 1.1 | 1.1 | 1.1 | 1.4 | 2.3 | 3.5 | · | |
| P / Cash Flow | -2.1 | -2.3 | -2.3 | · | -11.5 | -30.8 | -23.5 | |
| P / FCF | -2.1 | -2.2 | -2.3 | · | -10.3 | -19.6 | -17.2 | |
| Earnings Yield | -63.5% | -62.0% | -65.1% | -37.8% | -9.0% | -10.4% | -7.0% |
Gewinn- und Verlustrechnung 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $5M | · | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $22.0K | $21.0K | $22.0K | $22.0K | $30.0K | $-40.0K | $27.0K | |
| R&D Expense | $31M | $32M | $29M | $31M | $40M | $50M | $45M | $45M | $50M | $52M | $55M | $46M | $62M | $80M | $75M | $64M | |
| SG&A Expense | $21M | $14M | $14M | $14M | $14M | $15M | $16M | $16M | $16M | $17M | $17M | $17M | $19M | $19M | $21M | $19M | |
| Operating Expenses | $52M | $46M | $42M | $45M | $57M | $65M | $60M | $72M | $71M | $70M | $85M | $63M | $81M | $99M | $96M | $83M | |
| Operating Income | $-47M | $-46M | $-42M | $-45M | $-57M | $-65M | $-60M | $-72M | $-71M | $-70M | $-85M | $-63M | $-81M | $-99M | $-96M | $-83M | |
| Other Non-op | $-61.0K | $212.0K | $247.0K | $-81.0K | $-43.0K | $92.0K | $-2M | $-1M | $85.0K | $-929.0K | $-12M | $-5M | $-2M | $2M | $-10M | $-3M | |
| Net Income | $-43M | $-43M | $-39M | $-41M | $-51M | $-60M | $-60M | $-66M | $-66M | $-65M | $-86M | $-62M | $-79M | $-100M | $-103M | $-84M | |
| EPS (Basic) | $-0.13 | $-0.18 | $-0.17 | $-0.19 | $-0.23 | $-0.28 | $-0.27 | $-0.32 | $-0.35 | $-0.38 | $-0.49 | $-0.37 | $-0.54 | $-0.69 | $-0.72 | $-0.59 | |
| EPS (Diluted) | $-0.13 | $-0.18 | $-0.17 | $-0.19 | $-0.23 | $-0.28 | $-0.27 | $-0.32 | $-0.35 | $-0.38 | $-0.49 | $-0.37 | $-0.54 | $-0.69 | $-0.72 | $-0.59 | |
| Shares (Basic) | 328,930,269 | 240,290,782 | -435,704,178 | 222,038,680 | 218,929,548 | 215,358,619 | -373,531,795 | 209,188,551 | 190,026,638 | 169,128,362 | -302,076,887 | 167,649,010 | 146,795,826 | 144,563,829 | -285,255,907 | 143,661,721 | |
| Shares (Diluted) | 328,930,269 | 240,290,782 | -435,704,178 | 222,038,680 | 218,929,548 | 215,358,619 | -373,531,795 | 209,188,551 | 190,026,638 | 169,128,362 | -302,076,887 | 167,649,010 | 146,795,826 | 144,563,829 | -285,255,907 | 143,661,721 | |
| EBITDA | $-47M | $-43M | · | $-45M | $-57M | $-62M | · | $-72M | $-71M | $-70M | · | $-63M | $-81M | $-99M | · | $-82M |
Bilanz 19
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $39M | $30M | $52M | $38M | $52M | $42M | $75M | $51M | $171M | $51M | $83M | $69M | $155M | $110M | $62M | $74M | |
| Prepaid Expense | $7M | $6M | $8M | $9M | $10M | $12M | $11M | $13M | $12M | $11M | $10M | $8M | $10M | $10M | $12M | $17M | |
| Current Assets | $340M | $273M | $258M | $261M | $283M | $292M | $303M | $304M | $457M | $395M | $459M | $473M | $502M | $481M | $529M | $569M | |
| PP&E (Net) | $67M | $70M | $73M | $76M | $79M | $83M | $86M | $89M | $92M | $96M | $99M | $103M | $106M | $110M | $113M | $114M | |
| PP&E (Gross) | $145M | $145M | $145M | $145M | $146M | $149M | $149M | $149M | $148M | $151M | $151M | $150M | $150M | $150M | $150M | $149M | |
| Accum. Depreciation | $78M | $75M | $73M | $70M | $67M | $66M | $63M | $60M | $56M | $55M | $51M | $48M | $44M | $40M | $37M | $35M | |
| Other Non-current Assets | $4M | $4M | $4M | $4M | $4M | $2M | $2M | $5M | $6M | $5M | $7M | $10M | $9M | $9M | $10M | $9M | |
| Total Assets | $550M | $396M | $416M | $440M | $471M | $508M | $549M | $589M | $647M | $586M | $643M | $712M | $771M | $747M | $822M | $888M | |
| Accounts Payable | $6M | $5M | $4M | $4M | $5M | $5M | $5M | $6M | $13M | $6M | $6M | $6M | $10M | $15M | $14M | $11M | |
| Current Liabilities | $32M | $28M | $33M | $32M | $32M | $30M | $36M | $33M | $37M | $31M | $37M | $38M | $55M | $60M | $54M | $49M | |
| Capital Leases | $70M | $73M | $75M | $77M | $79M | $81M | $83M | $85M | $87M | $89M | $88M | $90M | $92M | $94M | $95M | $97M | |
| Other Non-current Liabilities | $12M | $16M | $16M | $15M | $15M | $11M | $8M | $8M | $8M | $5M | $5M | $1M | $2M | $2M | $6M | $2M | |
| Total Liabilities | $114M | $117M | $123M | $124M | $126M | $123M | $127M | $125M | $132M | $125M | $131M | $129M | $148M | $155M | $155M | $148M | |
| Common Stock | $345.0K | $245.0K | $229.0K | $223.0K | $220.0K | $219.0K | $212.0K | $210.0K | $209.0K | $170.0K | $169.0K | $168.0K | $167.0K | $146.0K | $144.0K | $144.0K | |
| Retained Earnings | $-2.10B | $-2.05B | $-2.01B | $-1.97B | $-1.93B | $-1.88B | $-1.82B | $-1.76B | $-1.69B | $-1.63B | $-1.56B | $-1.47B | $-1.41B | $-1.33B | $-1.23B | $-1.14B | |
| AOCI | $-518.0K | $-183.0K | $269.0K | $235.0K | $-45.0K | $43.0K | $-89.0K | $157.0K | $-780.0K | $-927.0K | $-955.0K | $-2M | $-4M | $-6M | $-10M | $-13M | |
| Stockholders' Equity | $436M | $279M | $293M | $315M | $345M | $385M | $422M | $464M | $515M | $461M | $512M | $583M | $623M | $592M | $667M | $740M | |
| Liabilities + Equity | $550M | $396M | $416M | $440M | $471M | $508M | $549M | $589M | $647M | $586M | $643M | $712M | $771M | $747M | $822M | $888M | |
| Shares Outstanding | 345,345,427 | 244,816,413 | 229,413,523 | 223,163,672 | 220,133,876 | 218,598,262 | 212,210,597 | 209,500,137 | 209,049,485 | 170,452,967 | 168,642,238 | 168,175,221 | 167,133,664 | 145,740,333 | 144,438,304 | 144,031,588 |
Cashflow 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $4M | · | · | · | · | |
| Stock-based Comp | $12M | $8M | $8M | $9M | $9M | $12M | $13M | $13M | $14M | $12M | $15M | $15M | $17M | $19M | $17M | $21M | |
| Restructuring | · | · | $0 | $0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | $19M | · | · | · | $-8M | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-32M | $-13M | $-28M | $-30M | $-39M | $-53M | $-37M | $-44M | $-64M | $-56M | $-54M | $-56M | $-62M | $-67M | $-62M | $-48M | |
| CapEx | $150.0K | $9.0K | $0 | $243.0K | $44.0K | $99.0K | $257.0K | $429.0K | $0 | $8.0K | $181.0K | $12.0K | $288.0K | $1M | $2M | $223.0K | |
| Investing Cash Flow | $-148M | $-30M | $34M | $12M | $44M | $6M | $55M | $-76M | $75M | $22M | $67M | $-34M | $17M | $113M | $50M | $25M | |
| Stock Issued | · | · | · | · | · | $10M | · | · | · | $0 | · | $3M | · | · | $0 | $0 | |
| Net Stock Activity | · | · | · | · | · | $10M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $188M | $21M | $8M | $3M | $5M | $14M | $6M | $679.0K | $109M | $2M | $155.0K | $4M | $90M | $2M | $46.0K | $1M | |
| Net Change in Cash | $8M | $-21M | $14M | $-15M | $10M | $-33M | $24M | $-119M | $120M | $-32M | $14M | $-86M | $45M | $48M | $-12M | $-22M | |
| Free Cash Flow | · | $-13M | · | · | · | $-53M | · | · | · | $-56M | · | · | · | $-68M | · | · |
Rentabilität 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1011.2% | · | · | · | · | · | · | · | · | -315927.3% | · | -146453.5% | -182995.5% | -190519.2% | · | -168344.9% | |
| Net Margin | -919.8% | · | · | · | · | · | · | · | · | -295454.6% | · | -142593.0% | -177247.7% | -189815.4% | · | -169689.8% | |
| EBITDA Margin | -1011.2% | · | · | · | · | · | · | · | · | -315927.3% | · | -146453.5% | -182995.5% | -190519.2% | · | -168344.9% | |
| ROA | -8.4% | -9.4% | · | -8.1% | -9.1% | -10.9% | · | -10.2% | -9.4% | -9.8% | · | -7.7% | -9.1% | -11.5% | · | -8.5% | |
| ROE | -10.9% | -12.8% | · | -10.6% | -11.8% | -14.1% | · | -12.7% | -11.7% | -12.3% | · | -9.3% | -10.9% | -13.6% | · | -9.7% |
Liquidität & Solvenz 2
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.7 | 9.6 | · | 8.2 | 8.9 | 9.7 | · | 9.3 | 12.3 | 12.8 | · | 12.6 | 9.2 | 8.1 | · | 11.6 | |
| Quick Ratio | 1.2 | 1.1 | · | 1.2 | 1.7 | 1.4 | · | 1.6 | 4.6 | 1.7 | · | 1.8 | 2.8 | 1.8 | · | 1.5 |
Effizienz 1
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Bewertung (TTM) 10
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $0 | · | $0 | $0 | $22.0K | · | $44.0K | $66.0K | $96.0K | · | $101.0K | $143.0K | $160.0K | · | $179.0K | |
| Net Income TTM | $-178M | $-195M | · | $-218M | $-243M | $-257M | · | $-260M | $-273M | $-306M | · | $-326M | $-344M | $-343M | · | $-321M | |
| Market Cap | $718M | $597M | · | $277M | $249M | $319M | · | $587M | $487M | $762M | · | $533M | $831M | $720M | · | $1.56B | |
| P/E | -2.8 | -2.8 | · | -1.2 | -1.0 | -1.1 | · | -2.0 | -1.4 | -2.3 | · | -1.4 | -2.1 | -2.1 | · | -4.7 | |
| P/S | · | · | · | · | · | 14507.0 | · | 13331.8 | 7380.1 | 7936.7 | · | 5278.4 | 5808.8 | 4499.7 | · | 8690.2 | |
| P/B | 1.6 | 2.1 | · | 0.9 | 0.7 | 0.8 | · | 1.3 | 0.9 | 1.7 | · | 0.9 | 1.3 | 1.2 | · | 2.1 | |
| P / Tangible Book | 1.6 | 2.1 | · | 0.9 | 0.7 | 0.8 | · | 1.3 | 0.9 | 1.7 | · | 0.9 | 1.3 | 1.2 | · | 2.1 | |
| P / Cash Flow | · | -46.3 | · | · | · | -6.0 | · | · | · | -13.6 | · | · | · | -10.8 | · | · | |
| P / FCF | · | -46.2 | · | · | · | -6.0 | · | · | · | -13.6 | · | · | · | -10.6 | · | · | |
| Earnings Yield | -35.1% | -36.1% | · | -82.3% | -104.4% | -91.1% | · | -50.7% | -70.4% | -44.3% | · | -69.1% | -47.9% | -48.6% | · | -21.1% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Umsatz | $0 | $22.0K | $95.0K | — | — |
| Betriebsgewinnmarge % | — | -1241813.6% | -344986.3% | — | — |
| Nettoergebnis | $-191M | $-258M | $-327M | — | — |
| Verwässerte EPS | $-0.87 | $-1.32 | $-2.09 | — | — |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Liquiditätsgrad | 7.9 | 8.5 | 12.4 | — | — |
| Quick Ratio | 1.6 | 2.1 | 2.2 | — | — |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-150M | $-201M | $-239M | — | — |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 231 Einreicher · $530.0M gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 37 (-10 vs. Vorquartal) | 24 (+13 vs. Vorquartal) | 90 (+13 vs. Vorquartal) | 55 (+12 vs. Vorquartal) | +123.4M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| Pfizer Inc | $46.928.245 | 22.032.040 | 8,85% | Aktien |
| Frazier Life Sciences Management, L.P. | $46.689.069 | 22.446.668 | 8,81% | Aktien |
| STATE STREET CORP | $39.573.718 | 19.025.826 | 7,47% | Aktien |
| TPG GP A, LLC | $38.929.916 | 18.716.306 | 7,34% | Aktien |
| Sio Capital Management, LLC | $27.712.736 | 13.323.431 | 5,23% | Aktien |
| PRIMECAP MANAGEMENT CO/CA/ | $27.296.756 | 13.123.440 | 5,15% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $25.306.603 | 12.166.636 | 4,77% | Aktien |
| FMR LLC | $24.957.776 | 11.998.931 | 4,71% | Aktien |
| CITADEL ADVISORS LLC | $19.676.871 | 9.460.034 | 3,71% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $16.191.444 | 7.784.348 | 3,05% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $12.494.150 | 6.005.150 | 2,36% | Aktien |
| GOLDMAN SACHS GROUP INC | $12.467.422 | 5.993.953 | 2,35% | Aktien |
| VANGUARD GROUP INC | $11.178.392 | 8.159.410 | 2,11% | Aktien |
| GordonMD Global Investments LP | $11.019.840 | 5.298.000 | 2,08% | Aktien |
| Patient Square Capital LP | $10.504.000 | 5.050.000 | 1,98% | Aktien |
| Aberdeen Group plc | $10.403.644 | 5.001.752 | 1,96% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $10.075.289 | 4.843.889 | 1,90% | Aktien |
| Woodline Partners LP | $9.361.298 | 4.500.624 | 1,77% | Aktien |
| Candriam S.C.A. | $9.010.818 | 4.336.296 | 1,70% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $8.761.122 | 4.212.078 | 1,65% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $7.975.369 | 3.834.312 | 1,50% | Aktien |
| Walleye Capital LLC | $6.797.465 | 3.268.012 | 1,28% | Aktien |
| RTW INVESTMENTS, LP | $6.760.000 | 3.250.000 | 1,28% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $6.397.849 | 3.075.889 | 1,21% | Aktien |
| Ghisallo Capital Management LLC | $6.240.000 | 3.000.000 | 1,18% | Aktien |
| Wildcat Capital Management, LLC | $6.075.237 | 2.920.787 | 1,15% | Aktien |
| BANK OF AMERICA CORP /DE/ | $6.043.750 | 2.905.649 | 1,14% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4.730.675 | 2.274.363 | 0,89% | Aktien |
| DAFNA Capital Management LLC | $4.160.000 | 2.000.000 | 0,78% | Aktien |
| TWO SIGMA ADVISERS, LP | $3.959.574 | 2.890.200 | 0,75% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $3.823.756 | 1.838.344 | 0,72% | Aktien |
| Boxer Capital Management, LLC | $3.120.000 | 1.500.000 | 0,59% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $3.026.614 | 1.455.103 | 0,57% | Aktien |
| Raiffeisen Bank International AG | $2.442.000 | 1.100.000 | 0,46% | Aktien |
| Vida Ventures Advisors, LLC | $2.229.722 | 1.798.163 | 0,42% | Aktien |
| BlackRock, Inc. | $2.142.876 | 1.030.229 | 0,40% | Aktien |
| Man Group plc | $1.459.954 | 701.901 | 0,28% | Aktien |
| RAYMOND JAMES FINANCIAL INC | $1.412.262 | 678.972 | 0,27% | Aktien |
| Mitsubishi UFJ Asset Management Co., Ltd. | $1.138.153 | 547.189 | 0,21% | Aktien |
| CITIGROUP INC | $1.038.914 | 499.478 | 0,20% | Aktien |
| Voleon Capital Management LP | $1.010.092 | 485.621 | 0,19% | Aktien |
| AMERIPRISE FINANCIAL INC | $977.182 | 469.799 | 0,18% | Aktien |
| TD Asset Management Inc | $961.126 | 462.080 | 0,18% | Aktien |
| MACKENZIE FINANCIAL CORP | $893.489 | 429.562 | 0,17% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $886.650 | 426.274 | 0,17% | Aktien |
| Erste Asset Management GmbH | $846.708 | 381.400 | 0,16% | Aktien |
| ALPS ADVISORS INC | $728.630 | 350.303 | 0,14% | Aktien |
| Rafferty Asset Management, LLC | $702.073 | 337.535 | 0,13% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $666.114 | 320.247 | 0,13% | Aktien |
| RHUMBLINE ADVISERS | $644.248 | 309.741 | 0,12% | Aktien |
| Moloney Securities Asset Management, LLC | $637.360 | 514.000 | 0,12% | Aktien |
| Harold Davidson & Associates Inc. | $585.566 | 281.522 | 0,11% | Aktien |
| IEQ CAPITAL, LLC | $582.257 | 279.931 | 0,11% | Aktien |
| Bank of New York Mellon Corp | $558.216 | 268.373 | 0,11% | Aktien |
| HSBC HOLDINGS PLC | $557.157 | 259.747 | 0,11% | Aktien |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO | $554.147 | 266.417 | 0,10% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $551.142 | 225.878 | 0,10% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $520.000 | 250.000 | 0,10% | Aktien |
| Squarepoint Ops LLC | $502.370 | 241.524 | 0,09% | Aktien |
| UBS Group AG | $494.220 | 237.606 | 0,09% | Aktien |
| BIT Capital GmbH | $478.400 | 230.000 | 0,09% | Aktien |
| WELLS FARGO & COMPANY/MN | $462.342 | 222.280 | 0,09% | Aktien |
| LPL Financial LLC | $458.994 | 220.670 | 0,09% | Aktien |
| Vanguard Global Advisers, LLC | $447.585 | 215.185 | 0,08% | Aktien |
| CAXTON ASSOCIATES LP | $439.589 | 206.380 | 0,08% | Aktien |
| Quadrature Capital Ltd | $437.825 | 210.493 | 0,08% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $431.400 | 207.404 | 0,08% | Aktien |
| Headlands Technologies LLC | $427.342 | 205.453 | 0,08% | Aktien |
| BARCLAYS PLC | $383.836 | 184.536 | 0,07% | Aktien |
| OpenArc Corporate Advisory, LLC | $362.457 | 174.258 | 0,07% | Aktien |
| CWM, LLC | $359.063 | 147.157 | 0,07% | Aktien |
| Virtus Investment Advisers, LLC | $358.195 | 172.209 | 0,07% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $354.432 | 170.400 | 0,07% | Kaufoption |
| PROFUND ADVISORS LLC | $352.972 | 169.698 | 0,07% | Aktien |
| PARTNERS CAPITAL INVESTMENT GROUP, LLP | $336.122 | 161.597 | 0,06% | Aktien |
| WINTON GROUP Ltd | $328.973 | 158.160 | 0,06% | Aktien |
| MetLife Investment Management, LLC | $324.844 | 156.175 | 0,06% | Aktien |
| Smartleaf Asset Management LLC | $306.080 | 137.874 | 0,06% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $305.000 | 146.779 | 0,06% | Aktien |
| JPMORGAN CHASE & CO | $291.295 | 131.214 | 0,05% | Aktien |
| MARSHALL WACE, LLP | $290.479 | 139.653 | 0,05% | Aktien |
| CHOREO, LLC | $260.129 | 125.062 | 0,05% | Aktien |
| ALGERT GLOBAL LLC | $254.634 | 122.420 | 0,05% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $254.234 | 122.228 | 0,05% | Aktien |
| Quantbot Technologies LP | $243.221 | 116.933 | 0,05% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $240.240 | 115.500 | 0,05% | Aktien |
| Graham Capital Management, L.P. | $237.992 | 114.419 | 0,04% | Aktien |
| Invesco Ltd. | $215.130 | 103.428 | 0,04% | Aktien |
| Engineers Gate Manager LP | $204.903 | 98.511 | 0,04% | Aktien |
| BANK OF NOVA SCOTIA | $202.592 | 97.400 | 0,04% | Aktien |
| Xcelsior Advisor Partners LLC | $199.661 | 95.991 | 0,04% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $194.773 | 93.641 | 0,04% | Aktien |
| AXQ CAPITAL, LP | $173.091 | 83.217 | 0,03% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $171.392 | 82.400 | 0,03% | Verkaufsoption |
| Mariner, LLC | $167.681 | 80.616 | 0,03% | Aktien |
| CAPTRUST FINANCIAL ADVISORS | $164.730 | 79.197 | 0,03% | Aktien |
| MORGAN STANLEY | $164.104 | 78.896 | 0,03% | Aktien |
| Police & Firemen's Retirement System of New Jersey | $162.822 | 78.280 | 0,03% | Aktien |
| D. E. Shaw & Co., Inc. | $157.196 | 75.575 | 0,03% | Aktien |
| CITADEL ADVISORS LLC | $149.344 | 71.800 | 0,03% | Kaufoption |
Unternehmensinsider 16 Insider · 6 Führungskräfte · 8 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Zachary Roberts | President and CEO | 1. Juli 2026 A | — | 0 | 0 | $0 |
| David D Chang | President and CEO | 23. März 2022 A | 2.289.652 | 0 | 0 | $0 |
| Eric Thomas Schmidt | Chief Financial Officer | 23. März 2022 A | 337.904 | 0 | 0 | $0 |
| Rafael Amado | EVP of R&D and CMO | 21. Juni 2022 S | 544.257 | 0 | 0 | $0 |
| Veer Bhavnagri | General Counsel | 23. März 2022 A | 589.279 | 0 | 0 | $0 |
| Alison Moore | Chief Technical Officer | 23. März 2022 A | 120.430 | 0 | 0 | $0 |
| Stephen Mayo | Direktor | 18. Juni 2026 A | — | 0 | 0 | $0 |
| Elizabeth A. Barrett | Direktor | 18. Juni 2026 A | — | 0 | 0 | $0 |
| Deborah M. Messemer | Direktor | 18. Juni 2026 A | 6.535 | 0 | 0 | $0 |
| Owen N. Witte | Direktor | 18. Juni 2026 A | 233.271 | 0 | 0 | $0 |
| Franz B Humer | Direktor | 18. Juni 2026 A | 191.892 | 0 | 0 | $0 |
| Joshua A Kazam | Direktor | 18. Juni 2026 A | 398.463 | 0 | 0 | $0 |
| Vicki L Sato | Direktor | 18. Juni 2026 A | 41.451 | 0 | 0 | $0 |
| Pfizer Inc. | 10%-Eigentümer | 15. Oktober 2018 C | 22.032.040 | 0 | 0 | $0 |
| Earl Martin Douglas | — | 2. Februar 2026 A | 564.948 | 0 | 1 | $-40.304 |
| Arie Belldegrun | — | 2. Februar 2026 A | 4.710.120 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 5 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Pfizer Inc. | 13. Februar 2026 | 9,00% | Änderung | — | SEC |
| Pfizer Inc. (“Pfizer”) ×3 Einreichungen | 25. Oktober 2023 | — | Erste Einreichung | — | SEC |
| TPG GP A, LLC, David Bonderman, James G. Coulter, Jon Winkelried | 18. Januar 2022 | — | Erste Einreichung | — | SEC |
| TPG Group Holdings (SBS) Advisors, Inc., David Bonderman, James G. Coulter ×4 Einreichungen | 10. August 2020 | — | Erste Einreichung | — | SEC |
| Pfizer Inc. (“ Pfizer ”) | 22. Oktober 2018 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 30 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| BBC · ETFis Series Trust I | 1,04% | 182.788 NS | 30. April 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,12% | 303.899 NS | 30. April 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,05% | 496.849 SH | 8. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,05% | 18.782 SH | 8. August 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,04% | 588.201 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 231.043 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,04% | 1.864.100 SH | 8. August 2026 | Täglich |
| IWN · iShares Trust | 0,03% | 2.455.219 SH | 8. August 2026 | Täglich |
| BIB · ProShares Trust | 0,02% | 8.308 NS | 31. Mai 2026 | N-PORT |
| SMLF · iShares Trust | 0,02% | 479.966 SH | 8. August 2026 | Täglich |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,02% | 1.528.157 SH | 8. August 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,02% | 27.987 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,02% | 6.776.183 SH | 8. August 2026 | Täglich |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,02% | 204.346 NS | 31. Mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,01% | 876.401 NS | 30. April 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,01% | 1.207.257 NS | 31. Mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,01% | 3.222.860 SH | 8. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,01% | 776.881 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,01% | 7.333 NS | 31. Mai 2026 | N-PORT |
| UWM · ProShares Trust | 0,01% | 5.734 NS | 31. Mai 2026 | N-PORT |
| URTY · ProShares Trust | 0,00% | 5.798 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 146 NS | 31. Mai 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 4.797 NS | 31. Mai 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 241.276 NS | 30. April 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 356.653 SH | 8. August 2026 | Täglich |
| DFUS · Dimensional ETF Trust | 0,00% | 63.774 NS | 30. April 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 149.554 NS | 31. Mai 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 25.280 SH | 8. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 8.666.591 SH | 8. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 22.307 SH | 8. August 2026 | Täglich |